E
Pasithea Therapeutics Corp.
KTTA
$1.19
-$0.02-1.65%
E
Sell
3/27/2024Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 3/27/2024 due to a decline in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 3/27/2024 due to a decline in the volatility index.
D
Sell
3/12/2024Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 3/12/2024 due to an increase in the total return index and volatility index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 3/12/2024 due to an increase in the total return index and volatility index.
E
Sell
2/26/2024Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 2/26/2024 due to a decline in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 2/26/2024 due to a decline in the volatility index.
D
Sell
2/9/2024Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 2/9/2024 due to an increase in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 2/9/2024 due to an increase in the volatility index.
E
Sell
1/23/2024Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 1/23/2024 due to a decline in the volatility index and total return index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 1/23/2024 due to a decline in the volatility index and total return index.
D
Sell
1/5/2024Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 1/5/2024 due to an increase in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 1/5/2024 due to an increase in the volatility index.
E
Sell
12/21/2023Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 12/21/2023 due to a decline in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 12/21/2023 due to a decline in the volatility index.
D
Sell
12/5/2023Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 12/5/2023 due to an increase in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 12/5/2023 due to an increase in the volatility index.
E
Sell
11/17/2023Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 11/17/2023 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 12.01 to 9.63.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 11/17/2023 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 12.01 to 9.63.
D
Sell
11/13/2023Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 11/13/2023 due to an increase in the volatility index and valuation index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 11/13/2023 due to an increase in the volatility index and valuation index.
E
Sell
10/27/2023Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 10/27/2023 due to a decline in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 10/27/2023 due to a decline in the volatility index.
D
Sell
10/12/2023Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 10/12/2023 due to an increase in the volatility index and total return index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 10/12/2023 due to an increase in the volatility index and total return index.
E
Sell
9/26/2023Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 9/26/2023 due to a decline in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 9/26/2023 due to a decline in the volatility index.
D
Sell
9/11/2023Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 9/11/2023 due to an increase in the volatility index, total return index and valuation index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 9/11/2023 due to an increase in the volatility index, total return index and valuation index.
E
Sell
3/14/2023Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 02/23/2023.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 02/23/2023.
E
Sell
2/8/2023Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index.
D
Sell
1/9/2023Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to D- from D on 1/9/2023 due to a decline in the volatility index and total return index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to D- from D on 1/9/2023 due to a decline in the volatility index and total return index.
D
Sell
12/23/2022Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D from D- on 12/23/2022 due to an increase in the volatility index, total return index and valuation index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D from D- on 12/23/2022 due to an increase in the volatility index, total return index and valuation index.
D
Sell
12/7/2022Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to D- from D on 12/7/2022 due to a decline in the volatility index and total return index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to D- from D on 12/7/2022 due to a decline in the volatility index and total return index.
D
Sell
11/21/2022Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D from D- on 11/21/2022 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 1,507.35% from $13.6 to $218.6.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D from D- on 11/21/2022 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 1,507.35% from $13.6 to $218.6.
D
Sell
8/17/2022Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 8/17/2022 due to an increase in the solvency index and growth index. Operating cash flow increased 5.95% from -$2.53M to -$2.38M.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 8/17/2022 due to an increase in the solvency index and growth index. Operating cash flow increased 5.95% from -$2.53M to -$2.38M.
E
Sell
8/1/2022Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 8/1/2022 due to a decline in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 8/1/2022 due to a decline in the volatility index.
D
Sell
7/14/2022Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 7/14/2022 due to an increase in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 7/14/2022 due to an increase in the volatility index.
E
Sell
6/24/2022Downgrade
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 6/24/2022 due to a decline in the volatility index and valuation index.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E+ from D- on 6/24/2022 due to a decline in the volatility index and valuation index.
D
Sell
6/2/2022Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 6/2/2022 due to an increase in the volatility index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to D- from E+ on 6/2/2022 due to an increase in the volatility index.
E
Sell
6/1/2022Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to E+ from E on 6/1/2022 due to a major increase in the solvency index, growth index and volatility index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to E+ from E on 6/1/2022 due to a major increase in the solvency index, growth index and volatility index.
E
Sell
3/2/2022Upgraded
Pasithea Therapeutics Corp. (KTTA) was upgraded to E from E- on 3/2/2022 due to an increase in the valuation index.
Pasithea Therapeutics Corp. (KTTA) was upgraded to E from E- on 3/2/2022 due to an increase in the valuation index.
E
Sell
12/8/2021None
Pasithea Therapeutics Corp. (KTTA) was downgraded to E- from U on 12/08/2021.
Pasithea Therapeutics Corp. (KTTA) was downgraded to E- from U on 12/08/2021.
NASDAQ
03/07/2025 4:00PM Eastern
Quotes delayed
